Intersect ENT, Inc., Now Part of Medtronic

๐Ÿ“ Menlo Park, United States๐Ÿ‘ฅ 150 employees๐Ÿ’ฐ Last funded 2015
Intersect ENT (Nasdaq:XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients. For additional information on the company or the products including risks and benefits please visit www.intersectENT.com
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
โ€”
Founded
Investor geography1 country
United States
2
Investor activity2013โ€“2015 ยท investors recorded per year
2013220151
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Intersect ENT, Inc., Now Part of Medtronic?
Intersect ENT, Inc., Now Part of Medtronic has 3 investors on record on gritt.io.
When did Intersect ENT, Inc., Now Part of Medtronic last raise funding?
The most recent investment in Intersect ENT, Inc., Now Part of Medtronic recorded on gritt.io was in 2015.
What industry is Intersect ENT, Inc., Now Part of Medtronic in?
Intersect ENT, Inc., Now Part of Medtronic operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Intersect ENT, Inc., Now Part of Medtronic based?
Intersect ENT, Inc., Now Part of Medtronic is headquartered in Menlo Park, United States.